GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lobe Sciences Ltd (XCNQ:LOBE) » Definitions » EPS (Diluted)

Lobe Sciences (XCNQ:LOBE) EPS (Diluted) : C$-0.02 (TTM As of Feb. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Lobe Sciences EPS (Diluted)?

Lobe Sciences's Earnings per Share (Diluted) for the three months ended in Feb. 2024 was C$-0.01. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2024 was C$-0.02.

Lobe Sciences's EPS (Basic) for the three months ended in Feb. 2024 was C$-0.01. Its EPS (Basic) for the trailing twelve months (TTM) ended in Feb. 2024 was C$-0.02.

Lobe Sciences's EPS without NRI for the three months ended in Feb. 2024 was C$-0.01. Its EPS without NRI for the trailing twelve months (TTM) ended in Feb. 2024 was C$-0.02.

During the past 3 years, the average EPS without NRIGrowth Rate was 41.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Lobe Sciences's highest 3-Year average EPS without NRI Growth Rate was 53.60% per year. The lowest was -72.40% per year. And the median was 17.85% per year.


Lobe Sciences EPS (Diluted) Historical Data

The historical data trend for Lobe Sciences's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lobe Sciences EPS (Diluted) Chart

Lobe Sciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Aug19 Aug20 Aug21 Aug22 Aug23
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.06 -0.30 -0.05 -0.32 -0.05

Lobe Sciences Quarterly Data
Dec18 Mar19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 Aug23 Nov23 Feb24
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.03 -0.01 - -0.01 -0.01

Competitive Comparison of Lobe Sciences's EPS (Diluted)

For the Biotechnology subindustry, Lobe Sciences's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lobe Sciences's PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lobe Sciences's PE Ratio distribution charts can be found below:

* The bar in red indicates where Lobe Sciences's PE Ratio falls into.



Lobe Sciences EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Lobe Sciences's Diluted EPS for the fiscal year that ended in Aug. 2023 is calculated as

Diluted EPS (A: Aug. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-4.707-0)/104.351
=-0.05

Lobe Sciences's Diluted EPS for the quarter that ended in Feb. 2024 is calculated as

Diluted EPS (Q: Feb. 2024 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-0.595-0)/79.136
=-0.01

EPS (Diluted) for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lobe Sciences  (XCNQ:LOBE) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Lobe Sciences EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Lobe Sciences's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Lobe Sciences (XCNQ:LOBE) Business Description

Traded in Other Exchanges
Address
1199 West Hastings Street, Suite 1400, Vancouver, BC, CAN, V6E 3T5
Lobe Sciences Ltd is a technology and services company that provides real estate, financial, management, IP, and branding support for the development of transformational medicine. It is working to develop effective psilocybin-based therapeutics for the treatment of mild traumatic brain injuries and post-traumatic stress disorder and devices for the efficient application of medications.

Lobe Sciences (XCNQ:LOBE) Headlines

No Headlines